• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IDEAYA Biosciences, Inc. - Common Stock (NQ:IDYA)

28.21 -0.63 (-2.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 867,842
Open 28.59
Bid (Size) 27.24 (200)
Ask (Size) 30.81 (900)
Prev. Close 28.84
Today's Range 27.88 - 29.18
52wk Range 17.17 - 39.28
Shares Outstanding 48,390,394
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data ↗
Today 0:05 EDT
IDEAYA Biosciences (NASDAQ:IDYA) said its lead oncology program remains on track for a regulatory submission after reporting positive top-line data in first-line metastatic melanoma, while also... 
Via MarketBeat
News headline image
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
May 14, 2026
From USA News Group
Via GlobeNewswire

Performance

YTD
-16.7%
-16.7%
1 Month
-16.8%
-16.8%
3 Month
-8.3%
-8.3%
6 Month
-15.4%
-15.4%
1 Year
+56.0%
+56.0%

More News

Read More
News headline image
Why IDEAYA Biosciences Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket ↗
April 13, 2026
Via Benzinga
News headline image
Get insights into the top gainers and losers of Friday's after-hours session. ↗
April 10, 2026
Via Chartmill
News headline image
A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you? ↗
March 15, 2026
Via The Motley Fool
A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗
January 15, 2026
Via Chartmill
News headline image
IDEAYA Biosciences Inc (NASDAQ:IDYA) Shows Strong Technical Setup for Potential Breakout ↗
December 22, 2025
Via Chartmill
News headline image
SLB To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
October 21, 2025
Via Benzinga
News headline image
Buying IDEAYA Might Be The Wrong IDYA Right Now ↗
September 16, 2025
Via Benzinga
News headline image
Alibaba To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
September 09, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
August 29, 2025
Via Benzinga
News headline image
IDEAYA (IDYA) Q2 Net Loss Improves 27% ↗
August 05, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
This Royal Caribbean Cruises Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday ↗
July 22, 2025
Via Benzinga
News headline image
This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗
June 26, 2025
Via Benzinga
News headline image
This NRG Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
June 26, 2025
Via Benzinga
News headline image
Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It ↗
November 15, 2024
Via Benzinga
News headline image
Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
November 11, 2024
From Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Via Business Wire
News headline image
This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗
November 05, 2024
Via Benzinga
News headline image
Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate ↗
September 23, 2024
Via Benzinga
News headline image
Oracle To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
September 10, 2024
Via Benzinga
News headline image
IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q2 2024 ↗
August 06, 2024
Via InvestorPlace
News headline image
Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal ↗
August 03, 2024
Via Talk Markets
News headline image
MarketBeat Week in Review – 7/15 - 7/19
July 20, 2024
Via MarketBeat
Topics Economy
News headline image
Positive News is Driving This Cancer Drug Maker’s Stock Higher
July 15, 2024
Via MarketBeat
News headline image
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
July 10, 2024
Via Benzinga

Frequently Asked Questions

Is IDEAYA Biosciences, Inc. - Common Stock publicly traded?
Yes, IDEAYA Biosciences, Inc. - Common Stock is publicly traded.
What exchange does IDEAYA Biosciences, Inc. - Common Stock trade on?
IDEAYA Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for IDEAYA Biosciences, Inc. - Common Stock?
The ticker symbol for IDEAYA Biosciences, Inc. - Common Stock is IDYA on the Nasdaq Stock Market
What is the current price of IDEAYA Biosciences, Inc. - Common Stock?
The current price of IDEAYA Biosciences, Inc. - Common Stock is 28.21
When was IDEAYA Biosciences, Inc. - Common Stock last traded?
The last trade of IDEAYA Biosciences, Inc. - Common Stock was at 05/15/26 04:00 PM ET
What is the market capitalization of IDEAYA Biosciences, Inc. - Common Stock?
The market capitalization of IDEAYA Biosciences, Inc. - Common Stock is 1.37B
How many shares of IDEAYA Biosciences, Inc. - Common Stock are outstanding?
IDEAYA Biosciences, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap